Leggett Thomas Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$593,354.40

Insider Activity of Leggett Thomas

According to the SEC Form 4 filings, Leggett Thomas, being in a position of

  1. Chief Financial Officer at Stoke Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4578 shares for $147,145,
    over all time since 2026-03-17, has bought 0 shares, and sold 4578 shares for $147,145.

Biography of Leggett Thomas

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$147,1452100

Comparison of Insiders on Amount of Buys and Sells

2026-03-18SaleStoke Therapeutics, Inc.
STOK
Chief Financial Officer
2,382
0.0042%
$31.34$74,663-1.77%
2026-03-17SaleStoke Therapeutics, Inc.
STOK
Chief Financial Officer
2,196
0.0039%
$33.01$72,482-7.26%
2021-01-08SaleBlack Diamond Therapeutics, Inc.
BDTX
Chief Financial Officer
3,000
0.0083%
$33.94$101,820-67.77%
2020-12-08SaleBlack Diamond Therapeutics, Inc.
BDTX
Chief Financial Officer
3,000
0.0082%
$33.78$101,327-62.42%
2020-11-09SaleBlack Diamond Therapeutics, Inc.
BDTX
Chief Financial Officer
6,000
0.0114%
$21.91$131,472-28.52%
2020-10-08SaleBlack Diamond Therapeutics, Inc.
BDTX
Chief Financial Officer
6,000
0.0111%
$22.19$133,156-25.34%
2020-09-14SaleBlack Diamond Therapeutics, Inc.
BDTX
Chief Financial Officer
6,000
0.0115%
$20.93$125,580-14.45%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.